Hologic’s 3Dimensions™ System for 3D Mammography Receives EUREF Type Test Certification
November 03 2022 - 8:00AM
Business Wire
3Dimensions System Earns Distinction for
Meeting or Exceeding Rigorous European Image Quality and Dose
Standards
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health,
announced today that its 3Dimensions™ mammography system was
awarded EUREF Type Test certification by the European Reference
Organisation for Quality Assured Breast Screening and Diagnostic
Services (www.EUREF.org).1 It is the first digital breast
tomosynthesis (DBT) system to receive such a distinction, and one
of only nine mammography systems overall to earn certification.
The mission of the nonprofit EUREF organisation is to raise
standards by bringing together the best examples of quality control
in mammography screening from regional and national breast cancer
programs across Europe. The type test certification assures
hospitals and imaging centers that the 3Dimensions 2D and 3D
systems have each passed a rigorous series of mechanical and
clinical tests demonstrating that the system meets the image
quality, radiation exposure and stability standards set by EUREF
for screening and diagnostic mammography equipment. Both
mammography systems were tested at two clinical sites in the
Netherlands for screening and diagnostic uses.
“The work being done by EUREF contributes greatly to ensuring
women receive quality screenings and care across Europe. We are
honored to be the first DBT system to meet their rigorous
standards,” said Tanja Brycker, Vice President, Strategic
Development, Breast & Skeletal Health and Gynaecological
Surgical Solutions at Hologic. “EUREF certification is not easy to
come by. We are proud that our 3Dimensions system has joined two of
our other mammography systems in being recognized. These
certifications reflect our commitment to developing high-quality
medical technology that improves women’s health.”
The 3Dimensions system features breakthrough improvements
designed to transform the patient experience without compromising
on speed, dose or accuracy. The system is the fastest, highest
resolution breast tomosynthesis system available,2 and is
clinically proven to be more comfortable3 for patients while
providing an enhanced workflow for radiologists. In addition to
this certification, EUREF has previously certified the company’s
Selenia® digital mammography and Selenia Dimensions® 2D
systems.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company
primarily focused on improving women’s health and well-being
through early detection and treatment. For more information on
Hologic, visit www.Hologic.com.
Hologic, 3Dimensions, Dimensions and Selenia are trademarks
and/or registered trademarks of Hologic, Inc., and/or its
subsidiaries in the United States and/or other countries.
Forward-Looking Statements
This news release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic products. There can be no assurance these products
will achieve the benefits described herein or that such benefits
will be replicated in any particular manner with respect to an
individual patient, as the actual effect of the use of the products
can only be determined on a case-by-case basis. In addition, there
can be no assurance that these products will be commercially
successful or achieve any expected level of sales. Hologic
expressly disclaims any obligation or undertaking to release
publicly any updates or revisions to any such statements presented
herein to reflect any change in expectations or any change in
events, conditions or circumstances on which any such data or
statements are based.
This information is not intended as a product solicitation or
promotion where such activities are prohibited. For specific
information on what products are available for sale in a particular
country, please contact a local Hologic sales representative or
write to womenshealth@hologic.com.
_____________________________________ 1 EUREF. Results EUREF
Type test.
https://www.euref.org/type-test-equipment/euref-type-test-results.
Last accessed 15 September 2022 2 Data on file and from public
sources, 2017 3 Smith, A. Improving Patient Comfort in Mammography.
Hologic WP-00119 Rev 003 (2017)
Source: Hologic, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221103005150/en/
Media Contact: Jane Mazur Vice President, Corporate
Communications +1.508.263.8764 jane.mazur@hologic.com Investor
Contact Ryan Simon Vice President, Investor Relations
+1.858.410.8514 ryan.simon@hologic.com
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Jul 2023 to Jul 2024